Sep 22, 2026 9 0
Uploaded by Jacob
Favorite
Share
More Options
22
CRISPR-Cas9 screening identifies ATOX1-driven cisplatin resistance mechanisms in liver cancer and evaluates targeted inhibitor efficacy_Page 1

Open in WPS to view all 22 pages